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following a hyperoxic injury to neonatal mouse
lung
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Background: The lungs of very preterm human babies display deficits in alveolarization and vascularization as a
result of the clinical use of high oxygen treatment (leading to hyperoxia) required to decrease the risk of mortality.
Detailed analyses of the persistence of the respiratory deficits following this treatment and means to restore a
normal state have not been investigated in full detail. In this study, high oxygen administration to neonatal mouse
lungs was established as a proxy to hyperoxia in human preterm infant lungs, to better characterize the associated
deficits and thus provide a means to assist in the development of treatments in the future.
Methods: Ninety percent oxygen was administered to newborn mice for four consecutive days. The effects of this
treatment upon alveolarization and vascularization were investigated by morphometric, histochemical,
immunohistochemical and protein analyses at day five (D5), D28 and D56 postpartum.
Results: Relative to control untreated lungs, septation of hyperoxic lungs was significantly reduced and airspaces
were significantly enlarged at all stages examined. Furthermore, compared to controls, the number of secondary
septa per tissue area was significantly reduced at D5, significantly increased at D28 and then the same as controls
at D56. Analysis of vascularization parameters indicated a reduction in mature blood vessel number and the
amount of Pecam1 at D5. Both of these parameters returned to control levels by D28.
Conclusions: This study suggests that administration of high oxygen to underdeveloped lungs has a transient
reductive effect on secondary septal number and pulmonary vascularization and a significant long-term reduction
in alveolarization persisting into adulthood. This model can be used for future research of premature lung disease
therapies in humans, addressing these short term septal and vascular and long term alveolar deficits, specifically
relating to injury by hyperoxia.
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Preterm birth occurs in approximately 10% of human
pregnancies between 20 and 37 weeks of gestation. During
this period, human lung development proceeds through
the canalicular and saccular stages and then on to the al-
veolar stage. This process is essential for gas-exchange
surface formation and optimization, and involves epithelial
wall thinning, epithelial cell differentiation and lung
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preterm babies are born with underdeveloped lungs. This
underdevelopment manifests a structural immaturity that
does not permit efficient gas exchange, and hence reduces
bloodstream oxygen levels. Although the cellular and mo-
lecular processes within the saccular and alveolar stages of
mice and humans show commonality, the developmental
timing of these stages is different between species. The
saccular stage of mouse lung development commences at
approximately embryonic day (E)17.5 and is not com-
pleted until approximately postnatal day five, whereas in
humans, the saccular stage commences during the 24th
week of gestation and is completed by birth [4,6]. TheLtd. This is an Open Access article distributed under the terms of the Creative
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at approximately three weeks postpartum, whereas human
alveolarization commences at 36 weeks of gestation and
ends after a few postnatal years [4,6,7]. This developmen-
tal anachrony between mice and humans means that new-
born mouse lungs may be conveniently used as a model
system for studying disease processes associated with pre-
term birth human saccular stage lungs.
Often in cases of human preterm birth, the gas exchange
tissues are underdeveloped and in order to provide an ad-
equate amount of oxygen in the bloodstream, oxygen con-
centration in the respired air must be increased, leading to
bronchopulmonary dysplasia (BPD). The influence of this
high oxygen exposure shortly after birth on lung structure,
as well as on proteins involved in vascularization and
alveolarization, has been investigated in a number of stud-
ies, using experimental animal models [8-12]. Generally it
is understood, that hyperoxia affects various parameters of
alveolarization, with the following reductions observed:
mean linear intercept, mean alveolar surface, secondary
crest number and alveolar number [8,10,12-14]. A signifi-
cant reduction in vascularization after hyperoxia in new-
born animals has also been reported. More specifically,
treatment with 80% oxygen reduces the number of pul-
monary blood vessels, as well as VefgA mRNA and VEGF
protein levels [6,8,11]. Lung fibrosis and elastic and colla-
gen fiber disorganization have also been observed after
hyperoxia exposure [12,13,15]. Previous studies have dem-
onstrated that changes in elastin depositions affect alveolar
formation [16]. Although it can be concluded that most es-
sential tissues involved in gas exchange are affected by
hyperoxia shortly after exposure, the precise timing and
duration of changes consequential to hyperoxia remain
undetermined. That is, whether these alterations to lung
structure, cellular and molecular parameters of the respira-
tory tissues are temporary, and whether any of them persist
into the adulthood, remains to be fully investigated.
The aim of this study, therefore, was to characterize in
detail temporal changes in saccular stage alveolar and vas-
cular development associated with hyperoxia in mice.
Newborn mice have been used as a model for human pre-
alveolarization state of lung development, when humans
are most likely to develop BPD when treated with high
oxygen. Mice were exposed to 90% oxygen from E17.5 to
D4 and analyses of alveolar, vascular and molecular
parameters were performed at three time points: day five
(D5), D28 and D56 postpartum. Both permanent and
transient alterations to alveolar and vascular architecture
and molecular biology were recorded during this period.
Methods
Mouse model of hyperoxia
All animal experimental methodology was approved by the
School of Biomedical Sciences Animal Ethics Committeeat Monash University, Australia. Pregnant C57Bl/6 J fe-
males housed in specific pathogen free (SPF) conditions
were brought into SPF procedure rooms of the animal
house at E14 and placed into clear plastic chambers
(length × width × height = 425 × 266 × 185 mm; floor
area 800 cm2 [Techniplast]). E0.5 was taken to represent
the morning of vaginal plug identification. Pregnant fe-
males were placed in the high oxygen environment at
E17.5 so that: (i) the pups would be born directly into
the high oxygen environment and (ii) the mothers
would have time to adjust to the high oxygen environ-
ment and thus reduce stress prior to parturition. Oxy-
gen concentrations were recorded using a portable gas
analyzer (Servomex 5200 Multi-Purpose) at 15 minute
(min) intervals throughout treatment. Oxygen levels
were maintained at 90 ± 5%, and returned to 20% (i.e.
room control concentrations) for 30 min each day dur-
ing compulsory animal monitoring periods and rotating
of natural mothers and foster mothers. The natural
mothers and foster mothers only, not the pups, were ro-
tated between hyperoxic and normoxic conditions to re-
duce stress and toxicity associated with hyperoxia to
them. The mothers were not the subject of this study,
only their pups. Pups and mothers were housed at one
litter per chamber for 24 hours (h). The number of pups
per chamber was equalized between hyperoxia and nor-
moxia (control) groups. Oxygen flow was turned off grad-
ually (reducing final oxygen concentration by 10% each
30 min) on the afternoon of postnatal day 4. Pups were
left to recover in room air for one day before the first set
of samples was collected. Pups remained in the same
cages until weaning at three weeks of age. Pups were
weighed once a week from D7 to D56. Both males and fe-
males were culled by cervical dislocation for analysis on
postnatal days five, 28 and 56. Lungs were isolated at each
time point for analysis.
Lung morphometric analysis
Lungs were pressure-fixed in situ via instillation with
4% paraformaldehyde (PFA) in phosphate buffer saline
(PBS) at 20 cm (H2O) via a cannula inserted into the
trachea [17]. PFA-saturated lungs were then excised
with rib-cages and post-fixed for 24 h in 4% PFA at 4°C.
The following day, lungs were removed and placed into
Zamboni’s fixative for 24 h at room temperature (RT)
[18]. Lungs were embedded in paraffin and serially sec-
tioned as 5–6 μm serial coronal sections in the ventral to
dorsal plane. Slides were randomly picked from each group
for staining and analysis. Sections on glass slides were
deparaffinized by immersion in xylene (3 × 5 min), 100%
ethanol (3 × 5 min) and tap water (1 min). Lung sections
were stained for histological analyses using four methods:
hematoxylin and eosin stain (Mayer’s hematoxylin – 3 min,
acid alcohol – 3 seconds (s), Scott’s tap water – 10 s,
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Masson’s trichrome stain (Celestin blue – 5 min, Mayer’s
hematoxylin – 3 min, acid alcohol – 3 s, Biebrich scarlet/
acid fuchsin – 5 min, 1% phosphomolybdic acid – 5 min,
aniline blue – 5 min, rinsing in tap water between solu-
tions), periodic acid and Schiff ’s (PAS) stain (periodic
acid – 5 min, Schiff ’s reagent – 5 min, hematoxylin –
5 min, acid alcohol – 3 s, Scott’s tap water – 10 s, rinsing
in tap water between solutions) and modified Weighert’s
elastin stain (0.25% potassium permanganate – 5 min, 5%
oxalic acid – 3 s, resorcin-fuchsin – overnight, tartazine in
saturated picric acid – 3 min, rinsing in tap water between
solutions) [18,19]. All stains were prepared according to
standard protocols [19]. After staining, slides were dehy-
drated in 100% ethanol and xylene (3 × 5 min) and
mounted in DPX mounting medium (BDH Laboratory
Supplies, #360294H) [19]. Five to seven photographs were
taken per section (depending on lung size) using a light
microscope (Olympus CKX41) and digital camera to assess
the entire alveolar area [15]. Photographs of lung sections
were analyzed for the following characteristics: mean linear
intercept (Lm), tissue area, alveolar number, elastin-positive
blood vessel number per tissue area, secondary septum
(crest) number per tissue area, elastin-positive tissue per
total tissue area, the presence of mucus and mucin-
secreting cells, the presence of collagen depositions and fi-
brosis. To evaluate the number of alveoli, three vertical
and two horizontal lines were drawn randomly across the
lung section image. The total lengths of vertical and hori-
zontal lines were equal. The summary length of all lines
per image was 3.63 mm. The average number of alveoli
was calculated from the number of airspaces (including al-
veolar ducts, but excluding airways) appearing on those
lines [15]. Mean linear intercept (Lm) was calculated from
measurements of the lengths of airspaces (both alveoli and
alveolar ducts, but excluding airways) falling on top of
these lines. The number of vertical measurements was
equal to the number of horizontal measurements. Second-
ary septa and blood vessels were detected by the presence
of elastin that was stained black by resorcin-fuchsin
(Weighert’s elastin stain) [20,21]. The number of secondary
septa and the amount of elastin were calculated in relation
to the area of tissue per total area of image. The number of
blood vessels was calculated both per total image area
and per tissue area. The tissue area was calculated using
Image-Pro Plus software (Media Cybernetics) by selecting
all colored pixels on the section image and then transfer-
ring them into microns according to the scale bar. The
amount of elastin was calculated by determining the total
percentage of elastin-positive tissue using Image-Pro Plus.
Immunohistochemistry
Lung paraffin sections were analyzed for the immuno-
reactivity to Pecam1 and Vegfa. Lung sections weredeparaffinized and rehydrated as described above, boiled
in 0.01 M sodium citrate solution for 20 min, left to cool
at RT for 30 min and then rinsed in distilled water
(dH2O). Slides were then incubated in 3% H2O2 for
10 min, rinsed in dH2O and blocked with 5% goat serum
at 4°C overnight. Lung sections were incubated with pri-
mary and secondary antibodies for one hour (1 h) at RT
in a wet chamber. Primary antibodies were used at the
following concentrations: Pecam1 (Abcam, #ab28364) at
1:100, Vegfa (Santa Cruz, #sc-152) at 1:750. Secondary
goat anti-rabbit biotinilated IgG antibody was used at
1:1000 (Invitrogen, #B2770). Streptavidin-HRP (DAKO,
#P0397) complex solution was applied and incubated for
30 min at RT. Sections were washed with PBS containing
1% Tween-20 (PBST) for 15 min (3 × 5 min) after each in-
cubation. DAB-chromogen in 1 ml of DAB-substrate buf-
fer complex (DAKO, #K3468) was applied for 5 min for
Pecam1 antibody and for 5–15 min for Vegfa antibody.
Sections were counter-stained with Mayer’s hematoxylin,
dehydrated with ethanol and xylene, and mounted in DPX
mounting medium.
Western blot analysis
Lung samples were snap-frozen in dry ice and stored
at −80°C for a maximum of 12 months. Frozen samples
were thawed and homogenized in 1 ml of radioimmuno-
precipitation assay buffer for 30 min, and centrifuged at
14000 rpm for 20 min at 4°C. Protein concentration was
measured in the supernatant using the Bradford protein
assay. Samples (the supernatant) were diluted in dH2O
to equalize protein concentrations, and further diluted
1:1 in reducing sample buffer and boiled for 5 min at
100°C, and then either stored at −20°C, or loaded into
7% or 12% polyacrylamide gels for Western blot analysis
as previously described [22]. Primary rabbit anti-mouse
antibodies were used at the following concentrations:
Pecam1 (Abcam, #ab28364) at 1:100, Vegfa (Santa Cruz,
#sc-152) at 1:200, or β-actin (Actb, Sigma, #A-2066) at
1:500. Membranes were manually exposed to X-ray film
(Fujifilm); the films were developed and scanned (Canon
Image Scanner), and the bands were analyzed using Ima-
geQuant TL gel analysis software.
Statistical analysis
A univariate general linear model, where group (i.e. hyper-
oxia/normoxia at each time point) was allocated as the
main factor and animal – as the random factor (five to
seven measurements per animal were taken, or in the case
of mean linear intercept – 160 measurements per animal),
was applied for analysis of variance to determine signifi-
cant differences in morphometric characteristics between
hyperoxic and control lungs at different stages using the
SPSS statistical package (PASW, IBM). The “litter” was
not included as a random variation factor since only one
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interaction analysis was performed, where group and time
were the main effects. Data plots were drawn in Micro-
soft Excel. Error bars indicate standard error of the
mean (SEM), and were calculated from average values
per mouse without taking into account variations within
each animal. One-way analysis of variance (ANOVA)
was used to determine significant differences in mouse
body weight, protein levels and the number of examined




Twenty-seven neonatal pups were exposed to 90% oxy-
gen for four days and 28 pups were maintained as con-
trols (normoxic mice). A total of 19 mice (nine males
and ten females) were culled at five days of age with 12
lungs from six males and six females pressure-fixed for
morphometric analysis and seven lungs from three males
and four females frozen for protein analysis. Fifteen mice
(nine males and six females) were culled at 28 days of
age (eight lungs from five males and three females for
morphometric analysis and seven lungs from four males
and three females for protein analysis). Twenty-one mice
(11 males and ten females) were culled at 56 days of age
(13 lungs from six males and seven females for morpho-
metric and eight lungs from five males and three females
for protein analysis). All 55 mice used in this data set
were treated and analyzed over a period of ten months
in three independent experimental pools.
Animal wellbeing
During the eight weeks following treatment both normoxic
and hyperoxic mice gained weight similarly (Figure 1) and
did not demonstrate any signs of distress (data not shown).
An exception was that during the first two postnatal weeks,
all hyperoxic mice demonstrated an abnormal breathing




















Figure 1 Body weight of male and female mice with
(hyperoxia) or without (normoxia) high oxygen treatment. Error
bars represent SEM, from D7 to D28 n = 6; from D35 to D56 n = 4.was being changed or when mice were being weighed,
breathing heavily with a ‘clicking’ noise. This sound was
not heard from normoxic mice during the same stress con-
ditions. There was no significant difference in mouse body
weight between normoxic and hyperoxic mice throughout
the whole experiment (Figure 1). Males and females were
compared separately, as males gained weight faster than fe-
males after 28 days.
Morphometric analysis of lungs after hyperoxia
Gender comparison
Males and females were first compared separately for
different morphometric parameters, however, no signifi-
cant gender differences were observed in parameter vari-
ations (data not shown). Therefore, for further analyses
males and females were pooled in both the hyperoxia
and normoxia groups.
Persistent changes in alveolarization
Persistent differences in specific lung morphometric
features were observed in respect to normoxia versus
hyperoxia. Hyperoxia induced a significant decrease in
average alveolar number, measured as airspaces per lin-
ear 3.63 mm, and this decrease was observed at each
time point examined: postpartum day five (D5), 49.88 ±
1.25 (hyperoxia, n = 6) versus 58.75 ± 0.63 (normoxia,
n = 6), P < 0.01; D28, 75.35 ± 1.42 (hyperoxia, n = 4) ver-
sus 84.10 ± 0.61 (normoxia, n = 4), P < 0.01; and D56,
72.52 ± 1.30 (hyperoxia, n = 6) versus 82.35 ± 1.61 (nor-
moxia, n = 6), P < 0.05; (five to seven measurements per
animal; Figure 2A). Accordingly to this alveolarization
decrease, hyperoxia induced a significant increase in
mean linear intercept (Lm) at each time point examined:
D5, 57.13 ± 2.20 μm (hyperoxia, n = 6) versus 45.02 ±
2.68 μm (normoxia, n = 6), P < 0.01; D28, 35.15 ±
1.30 μm (hyperoxia, n = 4) versus 31.64 ± 0.58 μm (nor-
moxia, n = 4), P < 0.01; and D56, 38.92 ± 1.75 μm (hyper-
oxia, n = 6) versus 33.61 ± 0.98 μm (normoxia, n = 6),
P < 0.01 (160 measurements per animal; Figure 2B). These
measurements of alveolar number and Lm, therefore,
demonstrate that hyperoxia in mouse pups causes an im-
mediate deficit in septation and that this decrease is not
reversed with time.
Temporary changes in tissue area, secondary septa and
elastin amount
In contrast to persistent changes in alveolar number
and Lm, other parameters measuring postnatal lung de-
velopment demonstrated transient and significant
changes that returned to control levels with time. For
example, lung tissue area per image in hyperoxic mice
was significantly decreased compared to normoxic mice
at D5, but was not significantly different at D28 and

















































































































































Figure 2 Statistical data for morphometric analysis of lungs after hyperoxia. Control (normoxia) – blue line, hyperoxia – red line. A. Average
number of airspaces falling on a 3.63 mm line drawn across the lung image, representing the average number of alveoli. B. Mean linear intercept,
representing the average size of alveoli and alveolar ducts in 1D. C. Tissue area per lung area, representing the average amount of tissue on the
area of lung section image. D. Average number of secondary septa per 1 mm2 of lung tissue area on the lung section image. E. Average ratio of
the area stained positively for elastin to lung tissue area. The differences between normoxia and hyperoxia values were calculated using a general
linear model (SPSS). P < 0.05 is marked as one asterisk, and P < 0.01 is marked as two asterisks. Error bars indicate SEM, n = 4-6. Plot interactions
are described in the text.
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(hyperoxia, n = 4) versus 38.01 ± 3.21% (normoxia, n = 4),
P = 0.05; and D56, 32.28 ± 2.17% (hyperoxia, n = 6) versus
33.77 ± 1.04% (normoxia, n = 6), P > 0.05; (Figure 2C). The
number of secondary septa per tissue area in hyperoxic
mice was significantly reduced compared to normoxic
mice at D5, significantly increased at D28, but was not sig-
nificantly different at D56 (measurements are given as
septum number per mm2 of tissue): D5, 259.94 ± 17.36
(hyperoxia, n = 6) versus 377.12 ± 27.57 (normoxia, n = 6),
P < 0.01; D28, 385.98 ± 33.92 (hyperoxia, n = 4) versus
291.83 ± 51.75 (normoxia, n = 4), P < 0.01; and D56,
323.74 ± 7.88 (hyperoxia, n = 6) vs 269.73 ± 38.32 (nor-
moxia, n = 6), P ≥ 0.05; (Figure 2D). Finally, elastin de-
posits were measured as a total elastin amount to provideinformation regarding changes in alveolar walls, septa and
blood vessels, and whether these changes were persistent.
These deposits on the tips of secondary septa, around
blood vessels and within alveolar walls (Figure 3) were
measured by Image-Pro Plus as a total elastin-positive
area per lung tissue area counted on a lung section area of
0.564 mm2 and were found to be significantly increased in
hyperoxic lungs compared to normoxic lungs at D5; how-
ever, no significant differences were observed at D28 and
D56: D5, 15.80 ± 1.92% (hyperoxia, n = 6) versus 10.40 ±
2.12% (normoxia, n = 6), P < 0.01 (Figure 2E). These re-
sults indicate that processes affecting lung tissue area,
secondary septa formation per tissue area and elastin
deposition during postnatal lung development, are sig-
nificantly affected during high oxygen treatment, but
Figure 3 Weighert’s elastin staining of control (normoxia) and hyperoxic (hyperoxia) lungs at D5, D28 and D56. Elastin is stained black.
Cytoplasm and nuclei of all cell types are stained yellow. Secondary septa (ss) are marked with black arrows, blood vessels surrounded by a layer
of elastin (v) are marked with red arrows, and elastin depositions in the alveolar walls (ad) are marked with blue arrows. Scale bar = 100 μm.
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rameters to control levels.
Timeline analysis of alveolarization parameters
Timeline analysis was performed to examine more spe-
cifically how morphometric parameters affected during
high oxygen treatment were maintained or altered with
time compared to normal development and growth. To
do this, changes in normoxic mouse development from
D5 to D28 to D56 were analyzed and then compared to
those of hyperoxic mice using interaction analysis. With
respect to the number of alveoli, there was no significant
interaction between normoxia and hyperoxia groups, with
the number of alveoli increasing from D5 to D28 and then
showing no change from D28 to D56 (Figure 2A). Mean
linear intercept (Lm) decreased from D5 to D28 in bothnormoxic and hyperoxic mice (P < 0.05) and then in-
creased from D28 to D56 (P < 0.05), with no significant
interaction between the plots (Figure 2B). There was also
no significant interaction between the plots for the lung
tissue area, i.e. time had similar effects on the lung tissue
area in both normoxic and hyperoxic groups (Figure 2C).
Although lung tissue area of both normoxic and hyperoxic
mice both increased from D5 to D28 (P < 0.05), it did not
change from D28 to 56 in the normoxic and hyperoxic
mice (Figure 2C). The plots for the number of secondary
septa per tissue area and the amount of elastin per tissue
area had a significant interaction (P < 0.05). The number
of secondary septa per tissue area decreased from D5 to
D28 in normoxic mice (P < 0.05), but increased during this
time in hyperoxic mice (P < 0.05; Figure 2D). Between
D28 and D56 the number of secondary septa decreased in
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normoxic mice. Lastly, the amount of elastin per tissue
area increased from D5 to D28 in normoxic mice (P <
0.05), but not in hyperoxic mice, where it was significantly
higher at D5 and persistently remained high, with a sig-
nificant interaction between the plots (P < 0.05, Figure 2E).
These data demonstrate that some morphometric param-
eters (number of alveoli, Lm and lung tissue area) develop
similarly in hyperoxia and normoxia groups during the
time examined, while other parameters (amount of elastin
and the number of secondary septa) do not.
Analysis of the lung vascularization after hyperoxia
Blood vessel number
In addition to studying morphometric changes of the lung
parenchyma following high oxygen treatment, changes to
the accompanying lung vasculature were also examined.
Significant differences were observed with respect to
blood vessel number per lung section area (i.e. including
airspaces) and blood vessel number per total tissue area
(i.e. excluding airspaces), and these differences were not
dependent on mouse gender. For example, the number of
blood vessels surrounded by an observable elastin layer
(Figure 3) per 0.564 mm2 of lung section area was signifi-
cantly decreased at D5 yet no differences were observed at
D28 or D56: D5, 12.41 ± 0.50 (hyperoxia, n = 6) versus
14.6 ± 0.62 (normoxia, n = 6); P < 0.05; (Figure 4A). With
respect to blood vessel number per total tissue area, there
was no significant difference at D5 and D56, yet at D28
hyperoxic lung vessel numbers per total tissue area were
significantly increased compared to normoxic lungs: D28,
115.81 ± 8.70 (hyperoxia, n = 4) versus 95.38 ± 7.34 (nor-
moxia, n = 4); P < 0.05 (Figure 4B).
Timeline analysis for blood vessel number
Timeline analysis was similarly performed as above to



























Figure 4 Statistical data for vascularization analysis of lungs after hyp
line. A. Average number of elastin-positive blood vessels on the lung sectio
tissue area. The differences between normoxia and hyperoxia values were
one asterisk. Error bars indicate SEM, n = 4-6. Plot interactions are describedaffected during high oxygen treatment were maintained
or altered with time compared to normal developmental
events. With respect to the number of blood vessels per
lung section area (including airspaces), there was a signifi-
cant increase in blood vessel number in both normoxia
and hyperoxia groups from D5 to D28 (P < 0.05 for both
groups). Subsequently, from D28 to D56, there was a sig-
nificant reduction in blood vessel number in the hyperoxia
group (P < 0.05), yet no reduction in the normoxia group.
Despite these differences between D28 to D56, and ac-
cording to interaction analyses, charts were parallel, i.e.
time had a similar effect on the number of blood vessels
in both treatments (Figure 4A). With respect to the num-
ber of blood vessels per lung tissue area, no significant dif-
ferences were seen in the normoxia group from D5 to
D56. However, the hyperoxia group demonstrated a sig-
nificant increase from D5 to D28 (P < 0.05) and a signifi-
cant decrease from D28 to D56 (P < 0.05; Figure 4B).
There was a significant interaction between normoxia
and hyperoxia charts (P < 0.05). Together, these data in-
dicate that early hyperoxia treatment exerts either a dir-
ect or indirect latent stimulatory effect upon vascular
development (observable at D28) and that these effects
are subsequently interpreted and normalized with re-
spect to surrounding tissue area by D56.Protein analysis for Pecam1 and Vegfa
With respect to mechanisms affecting changes to vascu-
lar development: (i) Pecam1 immunoreactivity as an
indicator of endothelial differentiation status and as a
blood vessel specific marker, and (ii) Vegfa immunore-
activity as an indicator of the level of influence of
alveolar epithelial type II cells (AECII) on vascular de-
velopment, were investigated by both Western blot ana-
lysis and immunohistochemistry. Pecam1 was localized
predominantly in blood vessel walls (i.e., endothelial





































eroxia. Control (normoxic lungs) – blue line, hyperoxic lungs – red
n image. B. Average number of elastin-positive blood vessels per lung
calculated using a general linear model (SPSS). P < 0.05 is indicated as
in the text.
Figure 5 Pecam1 protein analysis. A. Immunohistochemistry for Pecam1. Brown staining indicates localization of Pecam1 in the lung of
normoxic and hyperoxic mice at three time points (D5, D28 and D56). Mayer’s hematoxylin staining (dark blue) indicates nuclei. Blood vessels are
marked with arrows. Scale bar = 100 μm. B. Western blot for Pecam1 (140 kDa) in the lung at three time points (D5, D28 and D56). Actb is used
as the loading control (42 kDa). Norm – Normoxia, Hyp – Hyperoxia. C. Levels of Pecam1 per total protein (relative to Actb) according to the
Western blot. Error bars represent SEM, n = 3-4. Significant difference is marked with two asterisks (P < 0.01, n = 3-4).
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hyperoxic lungs compared to normoxic lungs at D5,
while no significant differences were observed at D28
and D56: D5, 12.22 ± 2.09% (hyperoxia, n = 3) versus79.92 ± 18.57% (normoxia, n = 4); P < 0.01 (Figure 5B, C).
Vegfa was localized predominantly in lung epithelial cells
(Figure 6A), which is consistent with the expression
of Vegfa by AECII [23]. Some Vegfa-immunoreactive
AB
Figure 6 Vegfa protein analysis. A. Immunohistochemistry for Vegfa on lung sections of normoxic and hyperoxic mice at three time points
(D5, D28, and D56). Brown staining indicates Vegfa (marked with arrows) and blue staining (Mayer’s hematoxylin counterstain) indicates nuclei.
Vegfa-positive cells associated with blood vessels are marked with arrows. Blood vessels are marked with “v”. Scale bar = 50 μm. B. Western blot
for Vegfa (21 kDa). Actb is used as the loading control (42 kDa). Norm – Normoxia, Hyp – Hyperoxia.
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(Figure 6A). No significant differences in Vegfa pro-
tein levels were observed at any time point examined
(Figure 6B).Assessment of respiratory fibrosis and airway mucus
following hyperoxia
As described above and following hyperoxia, an increase
in lung tissue elastin staining was observed at D5, but
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http://www.biomedcentral.com/1471-2466/14/59levels returned to control values by D28 (Figures 2 and 3).
Further, morphological analyses of lung tissue showed no
overt visible respiratory damage or pathological changes
in the lung after hyperoxia. No airway mucus and no obvi-
ous fibrosis or abnormal collagen deposits were observed
at any time point examined (Figure 7). Mucus-secreting
cells were observable in the trachea (Figure 7A), and
collagen deposits were localized around blood vessels
(Figure 7B), which indicated healthy lung morphology.Discussion
In this study we show that both alveolarization and
vascularization of neonatal mice are affected by hyper-
oxia, but to different degrees and to some extent inde-
pendently to each other. Septation parameters (number
of alveoli and Lm) were persistently affected by hyper-
oxia, whereas vascularization was only affected tempor-
arily. A temporarily reduced rate of secondary septal
number was associated with a reduction in the number
of alveoli and an increase in Lm, whereas temporarily re-
duced levels of vascular marker Pecam1 were associated
with a reduction in the total number of blood vessels
per section area. The reduced blood vessel number per
tissue area observed at D5 had normalized by D28 and
this measure was associated with a rise in Pecam1 levels.
The return of some parameters to control levels could
be attributed to a shorter hyperoxia exposure period
here compared to other studies: four days here and up
to 10 days in other studies [8,10,13,14].Figure 7 Assessment of airway mucus and respiratory fibrosis followi
reagent staining of normoxic and hyperoxic lung airways, counterstained w
purple and are marked with arrows. No mucus deposits are present in the
B. Representative images of Masson’s trichrome staining of normoxic and h
and blood vessels (bv) is present in both normoxic and hyperoxic lungs an
stained red. No abnormal collagen deposits (i.e. thickening of lung tissue aNeonatal mice treated with high oxygen just prior to
birth and for four days displayed no signs of pain or
distress, and did not lose weight in comparison to nor-
moxic control mice. No difference was also observed in
behavioral patterns (movement in the cage), and there
was no incidence of hyperoxia-induced mortality. After
high oxygen treatment heavy and loud breathing was no-
ticed in pups during handling, however, no mucus was
observed in the airways after mucin staining of lung sec-
tions. It was, therefore, concluded that the reason for
noisy breathing was not due to lower airway obstruction.
Previous studies have shown that the method of parafor-
maldehyde lung infusion and PAS staining is effective
for observing lung mucus [24]. There were also no signs
of fibrosis observed in the lung after collagen staining of
lung sections. Although not determined here, whether
the airway noises were associated with changes to upper
airway structures, for example, larynx, pharynx or nasal
structures, merits future analysis. Previous studies have
demonstrated an increase in fibrosis in the lungs after
hyperoxia, as well as disorganization of collagen deposits
[12,13]. The absence of these changes in the current study
could be explained by an initial very short oxygen expos-
ure in utero as well as a shorter treatment (four days com-
pared to ten days).
Pups were exposed to hyperoxia just prior to birth and
for the first four days postpartum, corresponding to the
saccular stage of lung development [6]. Alveolarization
in mice commences at approximately D5. During the al-
veolar stage, secondary septa begin to form and reshapeng hyperoxia. A. Representative images of periodic acid-Schiff’s
ith Mayer’s hematoxylin (blue). Mucin-secreting cells are stained
airways (aw) of either normoxic or hyperoxic mice. Scale bar = 100 μm.
yperoxic lungs. A collagen layer (stained blue) around the airways (aw)
d is marked with black arrows. Nuclei are stained purple, cytoplasm is
rea) are observed in hyperoxic lungs at any stage. Scale bar = 100 μm.
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fore, directly affects processes associated with the saccular
stage of lung development and this exposure has ramifica-
tions that were then measured in the alveolar stage. A
lower alveoli number and higher Lm were observed during
normal development at D5, compared to D28 and D56.
This may be explained by the fact that between D5 and
D28 the main steps of alveolarization occur: the number
of secondary septa per tissue area reduces as the number
of alveoli increases and Lm reduces. Between D28 and
D56 secondary septation overtly ceases, therefore, and as
observed here Lm and the number of alveoli do not mark-
edly change. At D5, the number of secondary septa per
tissue area in hyperoxic mice was reduced compared to
control levels, as was the number of alveoli, and this was
accompanied by a higher Lm. During the process of adap-
tation to normal oxygen conditions, the rate of secondary
septation then increased, such that the same number of
secondary septa per tissue area as normoxic mice at D5
was reached by D28. However, Lm remained high and al-
veolar number did not reach control levels even by D56.
This means, that there was a reduced contact area be-
tween air and lung tissue at all tested time points, includ-
ing D56, which would make breathing less efficient.
Therefore hyperoxia here caused a chronic lung septation
and respiratory deficit: the deficit persisting into adult-
hood. These results confirm previous studies of the effects
of hyperoxia on alveolarizaton [8,10,12-14].
No significant difference between tissue area in nor-
moxic and hyperoxic mice at D28 and D56 was observed,
indicating a partial recovery of the lung tissue. The tissue
area values however affected other parameters of lung
morphometry that were measured in relation to these
values, such as the amount of elastin, and secondary septa
and blood vessel number. Less elastin per tissue area was
observed at D5 in normoxic mice compared to hyperoxic
mice. However elastin levels increased by D28, whereas in
hyperoxic mice they were high at each time point exam-
ined. It can therefore be concluded that hyperoxia in-
creased elastin levels in the neonatal lung. This confirms
earlier studies that demonstrated that elastin deposits in
the lungs increase after both ventilation and hyperoxia
[25,26]. Elastin is produced by vascular smooth muscle
cells and surrounds mainly arteries, whereas veins have
less elastin, and in small capillaries there is very little or
no elastin [27]. Elastin is also present on the tips of
secondary septa [4]. Because the total number of blood
vessels per tissue area was not altered and secondary sep-
tal number per tissue area was decreased at D5, the rela-
tive increase in elastin levels in the D5 hyperoxic mice,
therefore, appears to be attributable to higher deposits at
pre-existing sites and also within alveolar walls. The disor-
ganized deposition of elastin and increased interstitial
elastin fibers have been reported in previous studies, whilechanges in the total amount of elastin were not [12,15].
The difference in our findings could be attributed to the
timing of hyperoxia exposure (E17.5-D4 vs D5-13 and
D0-D11), and/or species-specific difference [12,15].
Since the tissue area was reduced in hyperoxic mice at
D5, the number of elastin positive blood vessels was
therefore evaluated not only directly, but also in relation
to tissue area. As the tissue area increased to control
levels at D28 in hyperoxic mice, the number of elastin-
positive blood vessels also increased to reach control
levels. The lack of elastin-positive vessels after hyperoxia
at D5 may be related to reduced tissue area and reduced
Pecam1 levels, which were also observed at this stage. It
must be noted, however, that counting only elastin-
positive vessels does not include all types of blood vessels
and that the reduction in elastin positive blood vessels
may indicate the presence of smaller or less mature blood
vessels. Blood vessel growth was hyperstimulated in the
hyperoxic mouse lung after D5 such that by D28 the earl-
ier deficit had disappeared and both the number of blood
vessels per section area and the Pecam1 levels had reached
control levels. The amount of Vegfa remained unchanged
in hyperoxic lungs relative to normoxic lungs at all time
points examined. A significant reduction in Vegfa levels
has been demonstrated in previous studies after ten days
of high oxygen treatment (80%), compared to four days of
high oxygen treatment (90%) with a brief recovery period
in this study [8]. The differences in findings between pre-
vious studies and the study here may be attributable to
the differences in duration and timing of hyperoxia expos-
ure. By D56 there was no significant difference observed
in any vascular parameters measured. Therefore these
data indicate that the mechanisms regulating septation
and vascularization in the mouse lung display a certain
degree of independence.Conclusion
In conclusion, the hyperoxia model of four days of 90%
oxygen in newborn mice caused deficits in septation, lung
tissue area, alveolarization and respiratory vascularization.
While the deficits in secondary septa, lung tissue area and
vascularization were temporary, the deficit in alveolariza-
tion was permanent. Therefore, despite the absence of
(i) weight loss, (ii) mucus in the airways, and (iii) fibrosis,
four days of 90% oxygen treatment of newborn mice is
sufficient to produce a chronic deficiency in alveolariza-
tion. A means to normalize alveolarization and the signifi-
cance of, or connection to the temporary septal, tissue
area and vascular deficits requires addressing in the fu-
ture investigations.Competing interests
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